Trial Profile
A Randomized, Open Label, Multiple Dose, Cross-over, Phase I Trial to Evaluate a Pharmacokinetic Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Rosuvastatin/valsartan (Primary) ; Rosuvastatin; Valsartan
- Indications Atherosclerosis; Cardiovascular disorders; Heart failure; Hypercholesterolaemia; Hyperlipidaemia; Hypertension; Hypertriglyceridaemia; Myocardial infarction
- Focus Pharmacokinetics
- Sponsors LG Life Sciences
- 13 Aug 2013 New trial record